1. Validation of the risk factors for primary control of early T-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma by transoral surgery: a prospective observational study

   • Goshi Nishimura
   • Daisuke Sano
   • Nobuhiko Oridate

   Original Article 21 July 2021 Pages: 1995 - 2003

   

2. Potential intrinsic subtype dependence on the association between metformin use and survival in surgically resected breast cancer: a Korean national population-based study

   • Byoung Hyuck Kim
   • Moon-June Cho
   • Jeanny Kwon

   Original Article 10 August 2021 Pages: 2004 - 2016

   

3. Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer

   • Hiroya Taniguchi
   • Toshiki Masuishi
   • Takayuki Yoshino

   Original Article Open access 21 July 2021 Pages: 2017 - 2024

   

4. Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer

   • Hiroyuki Okuyama
   • Yoshinori Kagawa
   • Akihito Tsuji

   Original Article 02 September 2021 Pages: 2025 - 2028

5. Treatment outcome of laparoscopic surgery after self-expandable metallic stent insertion for obstructive colorectal cancer

   • Yukiharu Hiyoshi
   • Toshiki Mukai
   • Yosuke Fukunaga

   Original Article 28 July 2021 Pages: 2029 - 2036

   

6. Preoperative iron status is a prognosis factor for stage II and III colorectal cancer

   • Hiroshi Sawayama
   • Yuji Miyamoto
   • Hideo Baba

   Original Article 23 July 2021 Pages: 2037 - 2045

   

7. Tolerability and safety of adjuvant chemoradiotherapy with S-1 after limited surgery for T1 or T2 lower rectal cancer

   • Mitsuyoshi Tei
   • Shingo Noura
   • Hidetoshi Eguchi

   Original Article 27 July 2021 Pages: 2046 - 2052

   

8. EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma

   • Jia Wang
   • Yanlin Zhong
   • Guixia Meng

   Original Article 21 July 2021 Pages: 2053 - 2064

   

9. A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

   • Mitsuhito Sasaki
   • Hideki Ueno
   • Takuji Okusaka

   Original Article Open access 08 August 2021 Pages: 2065 - 2072

   

10. Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma

    • Motohide Uemura
    • Noboru Nakaigawa
    • Toyonori Tsuzuki

    Original Article Open access 21 July 2021 Pages: 2073 - 2084

    

11. Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma

    • Motohide Uemura
    • Noboru Nakaigawa
    • Toyonori Tsuzuki

    Correction Open access 27 August 2021 Pages: 2085 - 2086

12. Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab

    • Zine‐Eddine Khene
    • Romain Kokorian
    • Karim Bensalah

    Original Article 02 August 2021 Pages: 2087 - 2093

    

13. Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer

    • Yuto Baba
    • Eiji Kikuchi
    • Mototsugu Oya

    Original Article 06 August 2021 Pages: 2094 - 2103

    

14. Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy

    • Kota Iida
    • Makito Miyake
    • Kiyohide Fujimoto

    Original Article 27 July 2021 Pages: 2104 - 2112

    

15. Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up

    • Rihito Aizawa
    • Kiyonao Nakamura
    • Takashi Mizowaki

    Original Article 02 August 2021 Pages: 2113 - 2122

    

16. The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer

    • Masayuki Sekine
    • Takayuki Enomoto
    • Daisuke Aoki

    Original Article Open access 26 July 2021 Pages: 2123 - 2129

17. Correction to: The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer

    • Masayuki Sekine
    • Takayuki Enomoto
    • Daisuke Aoki

    Correction Open access 09 September 2021 Pages: 2130 - 2130

18. Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia

    • Naoko Hosono
    • Hisayuki Yokoyama
    • Tomoki Naoe

    Original Article Open access 07 August 2021 Pages: 2131 - 2141

    

19. Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse

    • Hiroshi Yasui
    • Masayuki Kobayashi
    • Yoichi Imai

    Original Article 14 July 2021 Pages: 2142 - 2150

    

20. Impact of sarcopenia in advanced and metastatic soft tissue sarcoma

    • Dennis Strassmann
    • Bennet Hensen
    • Philipp Ivanyi

    Original Article Open access 27 July 2021 Pages: 2151 - 2160